Avalon Technologies Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 8, 2025, 6:39 pm

Quick Insight

Avalon Technologies Ltd, with a current share price of ₹868 and a market cap of ₹5,775 Cr., presents a mixed financial picture. The high P/E ratio of 91.0 implies market expectations for strong future growth, yet the ROE of 11.0% and ROCE of 13.4% suggest room for improvement in capital efficiency. The company's OPM of 12% indicates a decent operational performance, supported by a Net Profit of ₹63 Cr. However, the elevated P/BV ratio of 8.20x and the moderate ICR of 7.90x raise concerns about valuation and debt coverage. With Promoters holding a majority stake and healthy reserves of ₹598 Cr., Avalon Technologies should focus on enhancing profitability and optimizing its capital structure to unlock shareholder value.

Competitors of Avalon Technologies Ltd

All Competitor Stocks of Avalon Technologies Ltd

Quarterly Result

Last Updated: May 31, 2025, 6:51 am

Below is a detailed analysis of the quarterly data for Avalon Technologies Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Sales, as of Mar 2025, the value is 343.00 Cr.. The value appears strong and on an upward trend. It has increased from 281.00 Cr. (Dec 2024) to 343.00 Cr., marking an increase of 62.00 Cr..
• For Expenses, as of Mar 2025, the value is 301.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 246.00 Cr. (Dec 2024) to 301.00 Cr., marking an increase of 55.00 Cr..
• For Operating Profit, as of Mar 2025, the value is 41.00 Cr.. The value appears strong and on an upward trend. It has increased from 35.00 Cr. (Dec 2024) to 41.00 Cr., marking an increase of 6.00 Cr..
• For OPM %, as of Mar 2025, the value is 12.00%. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 12.00%.
• For Other Income, as of Mar 2025, the value is 3.00 Cr.. The value appears to be declining and may need further review. It has decreased from 10.00 Cr. (Dec 2024) to 3.00 Cr., marking a decrease of 7.00 Cr..
• For Interest, as of Mar 2025, the value is 4.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 5.00 Cr. (Dec 2024) to 4.00 Cr., marking a decrease of 1.00 Cr..
• For Depreciation, as of Mar 2025, the value is 8.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 7.00 Cr. (Dec 2024) to 8.00 Cr., marking an increase of 1.00 Cr..
• For Profit before tax, as of Mar 2025, the value is 33.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 33.00 Cr..
• For Tax %, as of Mar 2025, the value is 25.00%. The value appears to be improving (decreasing) as expected. It has decreased from 27.00% (Dec 2024) to 25.00%, marking a decrease of 2.00%.
• For Net Profit, as of Mar 2025, the value is 24.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 24.00 Cr..
• For EPS in Rs, as of Mar 2025, the value is 3.67. The value appears strong and on an upward trend. It has increased from 3.63 (Dec 2024) to 3.67, marking an increase of 0.04.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: June 16, 2025, 2:45 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: July 25, 2025, 1:47 pm

Below is a detailed analysis of the balance sheet data for Avalon Technologies Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 13.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 13.00 Cr..
• For Reserves, as of Mar 2025, the value is 598.00 Cr.. The value appears strong and on an upward trend. It has increased from 534.00 Cr. (Mar 2024) to 598.00 Cr., marking an increase of 64.00 Cr..
• For Borrowings, as of Mar 2025, the value is 180.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 209.00 Cr. (Mar 2024) to 180.00 Cr., marking a decrease of 29.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 248.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 173.00 Cr. (Mar 2024) to 248.00 Cr., marking an increase of 75.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 1,040.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 929.00 Cr. (Mar 2024) to 1,040.00 Cr., marking an increase of 111.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 185.00 Cr.. The value appears strong and on an upward trend. It has increased from 147.00 Cr. (Mar 2024) to 185.00 Cr., marking an increase of 38.00 Cr..
• For CWIP, as of Mar 2025, the value is 10.00 Cr.. The value appears to be declining and may need further review. It has decreased from 20.00 Cr. (Mar 2024) to 10.00 Cr., marking a decrease of 10.00 Cr..
• For Investments, as of Mar 2025, the value is 35.00 Cr.. The value appears to be declining and may need further review. It has decreased from 75.00 Cr. (Mar 2024) to 35.00 Cr., marking a decrease of 40.00 Cr..
• For Other Assets, as of Mar 2025, the value is 810.00 Cr.. The value appears strong and on an upward trend. It has increased from 687.00 Cr. (Mar 2024) to 810.00 Cr., marking an increase of 123.00 Cr..
• For Total Assets, as of Mar 2025, the value is 1,040.00 Cr.. The value appears strong and on an upward trend. It has increased from 929.00 Cr. (Mar 2024) to 1,040.00 Cr., marking an increase of 111.00 Cr..

Notably, the Reserves (598.00 Cr.) exceed the Borrowings (180.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Avalon Technologies Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 9.62. This value is within the healthy range. It has increased from 4.29 (Mar 24) to 9.62, marking an increase of 5.33.
• For Diluted EPS (Rs.), as of Mar 25, the value is 9.48. This value is within the healthy range. It has increased from 4.19 (Mar 24) to 9.48, marking an increase of 5.29.
• For Cash EPS (Rs.), as of Mar 25, the value is 13.91. This value is within the healthy range. It has increased from 7.74 (Mar 24) to 13.91, marking an increase of 6.17.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 92.44. It has increased from 83.29 (Mar 24) to 92.44, marking an increase of 9.15.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 92.44. It has increased from 83.29 (Mar 24) to 92.44, marking an increase of 9.15.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 165.99. It has increased from 131.96 (Mar 24) to 165.99, marking an increase of 34.03.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 19.95. This value is within the healthy range. It has increased from 11.77 (Mar 24) to 19.95, marking an increase of 8.18.
• For PBIT / Share (Rs.), as of Mar 25, the value is 15.63. This value is within the healthy range. It has increased from 8.29 (Mar 24) to 15.63, marking an increase of 7.34.
• For PBT / Share (Rs.), as of Mar 25, the value is 13.11. This value is within the healthy range. It has increased from 5.79 (Mar 24) to 13.11, marking an increase of 7.32.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 9.59. This value is within the healthy range. It has increased from 4.26 (Mar 24) to 9.59, marking an increase of 5.33.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 9.59. This value is within the healthy range. It has increased from 4.26 (Mar 24) to 9.59, marking an increase of 5.33.
• For PBDIT Margin (%), as of Mar 25, the value is 12.01. This value is within the healthy range. It has increased from 8.92 (Mar 24) to 12.01, marking an increase of 3.09.
• For PBIT Margin (%), as of Mar 25, the value is 9.41. This value is below the healthy minimum of 10. It has increased from 6.27 (Mar 24) to 9.41, marking an increase of 3.14.
• For PBT Margin (%), as of Mar 25, the value is 7.89. This value is below the healthy minimum of 10. It has increased from 4.38 (Mar 24) to 7.89, marking an increase of 3.51.
• For Net Profit Margin (%), as of Mar 25, the value is 5.77. This value is within the healthy range. It has increased from 3.22 (Mar 24) to 5.77, marking an increase of 2.55.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 5.77. This value is below the healthy minimum of 8. It has increased from 3.22 (Mar 24) to 5.77, marking an increase of 2.55.
• For Return on Networth / Equity (%), as of Mar 25, the value is 10.37. This value is below the healthy minimum of 15. It has increased from 5.11 (Mar 24) to 10.37, marking an increase of 5.26.
• For Return on Capital Employeed (%), as of Mar 25, the value is 15.40. This value is within the healthy range. It has increased from 8.37 (Mar 24) to 15.40, marking an increase of 7.03.
• For Return On Assets (%), as of Mar 25, the value is 6.10. This value is within the healthy range. It has increased from 3.00 (Mar 24) to 6.10, marking an increase of 3.10.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.03. This value is below the healthy minimum of 0.2. It has decreased from 0.09 (Mar 24) to 0.03, marking a decrease of 0.06.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.23. This value is within the healthy range. It has decreased from 0.29 (Mar 24) to 0.23, marking a decrease of 0.06.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.11. It has increased from 0.82 (Mar 24) to 1.11, marking an increase of 0.29.
• For Current Ratio (X), as of Mar 25, the value is 2.22. This value is within the healthy range. It has decreased from 2.53 (Mar 24) to 2.22, marking a decrease of 0.31.
• For Quick Ratio (X), as of Mar 25, the value is 1.30. This value is within the healthy range. It has decreased from 1.40 (Mar 24) to 1.30, marking a decrease of 0.10.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 2.20. This value is below the healthy minimum of 4. It has increased from 1.74 (Mar 24) to 2.20, marking an increase of 0.46.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 7.90. This value is within the healthy range. It has increased from 4.72 (Mar 24) to 7.90, marking an increase of 3.18.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 4.80. This value is within the healthy range. It has increased from 2.71 (Mar 24) to 4.80, marking an increase of 2.09.
• For Enterprise Value (Cr.), as of Mar 25, the value is 5,057.00. It has increased from 3,300.31 (Mar 24) to 5,057.00, marking an increase of 1,756.69.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 4.61. This value exceeds the healthy maximum of 3. It has increased from 3.81 (Mar 24) to 4.61, marking an increase of 0.80.
• For EV / EBITDA (X), as of Mar 25, the value is 38.31. This value exceeds the healthy maximum of 15. It has decreased from 42.66 (Mar 24) to 38.31, marking a decrease of 4.35.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 4.57. This value exceeds the healthy maximum of 3. It has increased from 3.74 (Mar 24) to 4.57, marking an increase of 0.83.
• For Price / BV (X), as of Mar 25, the value is 8.20. This value exceeds the healthy maximum of 3. It has increased from 5.92 (Mar 24) to 8.20, marking an increase of 2.28.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 4.57. This value exceeds the healthy maximum of 3. It has increased from 3.74 (Mar 24) to 4.57, marking an increase of 0.83.
• For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness